Community-based Rehabilitation Management for Patients With Remitted Geriatric Depression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

EARLY_PHASE1

Total Enrollment

120 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2026-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study intends to take patients with RGD as objects. Further construct a community-based rehabilitation management (CBRM) program with drug treatment, rehabilitation measures of education, psychology and exercise as its core content on the basis of evidence-based practice approach. Based on the cost-utility analysis of health economics, the health and economic benefits of the CBRM program will be evaluated, and a theoretical reference will be provided for community health institutions to carry out whole-course rehabilitation management practice and health policy formulation.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of a PMT Rehabilitation Nursing Plan for the Older Adults With MCI to Promote Cognitive Health

NCT07089654

Mild Cognitive Impairment (MCI)

NOT_YET_RECRUITING NA

Enhanced Medical Rehabilitation in Older Adults

NCT02114879

Disabling Medical Events Disabled Depression

COMPLETED NA

Comprehensive Dementia Management : From Translational Medicine to Innovative Care

NCT06214962

Exercise

RECRUITING

Risk Prediction and Its Intelligent Assessment for Cognitive Impairment Among Community-dwelling Older Adults

NCT05385874

Cognitive Impairment Predictive Model Aging +1 more

COMPLETED

Behavioral Interventions to Prevent or Delay Dementia

NCT02265757

Mild Cognitive Impairment Memory Disorders Mild Dementia +6 more

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Based on the background of population aging, the prevalence of Late life depression tends to increase, and the recurrence rate after antidepressants treatment is still as high as 35%-57%, and the disease course tends to be chronic. Therefore, the formulation and implementation of prevention and control programs have become a significant part of the government's work plan. Physical frailty symptoms such as loss of daily activities and weakness are common in patients with remitted geriatric depression (RGD), and cognitive impairment is also considered to be an independent persistent symptom of RGD patients, which are related to the fluctuation and recurrence of depressive symptoms in elderly patients. Physical cognitive decline syndrome (PCDS) can comprehensively assess the physical frailty symptoms and the degree of cognitive impairment of the elderly, and effectively predict the course of the disease and the trend of healthy development. However, studies applied to the field of emotional disorder have not been retrieved. Therefore, this study intends to take patients with RGD as objects to investigate the prevalence of PCDS, build a risk prediction model and reveal it is warning mechanisms. That is, after determinning the basis of risk factors affecting the occurence of PCDS in RGD patients, we will carry out the formulation, implementation and evaluation of the follow-up CBRM program.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Geriatric Depression

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

case group,

Patients in case group will be treated with CBRM program

Group Type EXPERIMENTAL

CBRM (community-based rehabilitation management)

Intervention Type COMBINATION_PRODUCT

The case group patients will undergo drug treatment (Selective Serotonin Reuptake Inhibitors), health education, cognitive-motor dual task training, cognitive-training.

control group

the control group patients will be treated routinely as usual.

Group Type OTHER

TAR(treatment as routine)

Intervention Type COMBINATION_PRODUCT

Patients in control group will be treated rountinely which includes drug treatment (SSRIs) and traditional health education.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CBRM (community-based rehabilitation management)

The case group patients will undergo drug treatment (Selective Serotonin Reuptake Inhibitors), health education, cognitive-motor dual task training, cognitive-training.

Intervention Type COMBINATION_PRODUCT

TAR(treatment as routine)

Patients in control group will be treated rountinely which includes drug treatment (SSRIs) and traditional health education.

Intervention Type COMBINATION_PRODUCT

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* aged 60 years old or above at the time of enrollment;
* meet the diagnostic criteria for MDD without psychotic features according to DSM-5, and depressive symptoms have been improved and remained stable for at least 2 months after treatment with SSRIs;
* the total score of HAMD-17 is less than 7 at the time of enrollment;
* meet the diagnostic criteria for physio-cognitive decline: 1) the total score of ADL and IADL was less than 26; 2)cognitve decline: first, subjects with severe impairment of cognitive function will be excluded (years of education ≥ 6, MMSE scores \<24；years of education \<6 years, MMSE total score \<14). After completing a neuropsychological task, cogintive declined will be confirmed when any aspects of cognitve function is 1.5 standard deviations lower than that of normal elderly; 3) the grip strength is weakened, and the domaint hand grip strength is \< 28kg for males or \<18kg for females; 4)slow step speed, that is, in a space of length \>10 meters, the subjects walks 6 meters from the starting point at a normal and uniform pace, and the pace is \<1m/s.
* comprehension, reading and writing skills to complete the measurements or complete them with assistance of the researchers with obstacles;
* voluntary participation and signed informed consent.

Exclusion Criteria

* meet the diagnostic of schizophrenia, bipolar disorder, dementia;
* comorbidity of physical diseases, such ascardiovascular and cerebrovascular diseases, rheumatoid arthritis, stroke and malignant tumors;
* history of alcohol or drug dependence;
* severe deformity of spine and limbs;
* complete or partial dependence on caregivers for daily life, such as long-term bedridden, wheelchair assisted;
* have received physical therapy or psychological treatment in the past three months;
* currently participating in other clinical research.

Minimum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes